CSL (Germany) Today
| CSJ Stock | EUR 142.92 5.54 4.03% |
PerformanceModest
| Odds Of DistressLow
|
CSL is trading at 142.92 as of the 20th of July 2025. This is a 4.03 percent increase since the beginning of the trading day. The stock's lowest day price was 142.92. CSL has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 21st of April 2025 and ending today, the 20th of July 2025. Click here to learn more.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. The company has 482.22 M outstanding shares. More on CSL Limited
Moving together with CSL Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
CSL Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CSL's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CSL or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
CSL Limited (CSJ) is traded on Frankfurt Exchange in Germany and employs 30,000 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 89.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSL's market, we take the total number of its shares issued and multiply it by CSL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CSL Limited classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 482.22 M outstanding shares.
CSL Limited has accumulated about 668.7 M in cash with 2.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.48.
Check CSL Probability Of Bankruptcy
Ownership AllocationCSL holds a total of 482.22 Million outstanding shares. 30% of CSL Limited outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CSL Ownership Details
CSL Limited Risk Profiles
Although CSL's alpha and beta are two of the key measurements used to evaluate CSL's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.13 | |||
| Semi Deviation | 1.35 | |||
| Standard Deviation | 1.53 | |||
| Variance | 2.35 |
CSL Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CSL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
CSL Corporate Management
Elected by the shareholders, the CSL's board of directors comprises two types of representatives: CSL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSL. The board's role is to monitor CSL's management team and ensure that shareholders' interests are well served. CSL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BCom BComm | Chief Officer | Profile | |
| Paul McKenzie | Chief Officer | Profile | |
| Christina Hickie | Sr Communications | Profile | |
| Wilfried Freudenberg | Department Production | Profile | |
| BS BS | Exec Counsel | Profile | |
| MS BA | Ex Officer | Profile | |
| Paul BA | CEO MD | Profile |
Other Information on Investing in CSL Stock
CSL financial ratios help investors to determine whether CSL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.